Current status and future perspective for oncogene analysis and molecular target therapy in non-small cell lung cancer

被引：0
|
作者：
Takahashi, Kazuhisa [1 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Dept Resp Med, Tokyo, Japan
来源：
GENES & GENETIC SYSTEMS | 2016年 / 91卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
S2-5
引用
收藏
页码：319 / 319
页数：1
相关论文
共 50 条
  • [31] CURRENT STATUS OF CHEMOTHERAPY FOR NON-SMALL CELL LUNG-CANCER
    AISNER, J
    HANSEN, HH
    CANCER TREATMENT REPORTS, 1981, 65 (11-1): : 979 - 986
  • [32] Non-small cell lung cancer: current treatment and future advances
    Zappa, Cecilia
    Mousa, Shaker A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (03) : 288 - 300
  • [33] The current status of docetaxel for advanced non-small cell lung cancer
    Green, MR
    ANTI-CANCER DRUGS, 2001, 12 : S11 - S16
  • [34] Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
    Umair Majeed
    Rami Manochakian
    Yujie Zhao
    Yanyan Lou
    Journal of Hematology & Oncology, 14
  • [35] Targeted therapy in advanced non-small cell lung cancer: current advances and future trends
    Majeed, Umair
    Manochakian, Rami
    Zhao, Yujie
    Lou, Yanyan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [36] STATUS OF IMMUNE THERAPY IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Parums, D. V.
    DRUGS OF THE FUTURE, 2014, 39 (07) : 469 - 477
  • [37] The prognostic biological markers of immunotherapy for non-small cell lung cancer: current landscape and future perspective
    Liang, Shuai
    Wang, Hanyu
    Tian, Haixia
    Xu, Zhicheng
    Wu, Min
    Hua, Dong
    Li, Chengming
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [38] Immune therapy of non-small cell lung cancer. The future
    Bobbio, Antonio
    Alifano, Marco
    PHARMACOLOGICAL RESEARCH, 2015, 99 : 217 - 222
  • [39] Neoadjuvant targeted therapy for resectable EGFR-mutant non-small cell lung cancer: Current status and future considerations
    Liu, Wenliang
    Ren, Siying
    Xiao, Ying
    Yang, Lulu
    Zeng, Chao
    Hu, Yan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [40] Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions
    Riudavets, Mariona
    Cascetta, Priscilla
    Planchard, David
    LUNG CANCER, 2022, 169 : 102 - 114
12345